David Chiu, MD, FAHA

  • Houston Methodist stroke neurologist
  • Director of the Houston Methodist Eddy Scurlock Stroke Center
  • Elizabeth Blanton Wareing Chair in the Houston Methodist Eddy Scurlock Stroke Center
  • Professor of clinical neurology, Weill Cornell Medical College

David Chiu, MD, FAHA

Areas of Expertise

  • Arteriovenous malformations
  • Brain aneurysms
  • Carotid surgery and angioplasty/stenting
  • Cerebrovascular accidents
  • Stroke
  • Stroke recovery and rehabilitation
  • Transient ischemic attacks


American Board of Psychiatry and Neurology, Neurology and Vascular Neurology
Yale University School of Medicine, New Haven, Connecticut | 1990
University of California San Francisco, School of Medicine, San Francisco, California
Neurology, University of California San Francisco, School of Medicine, San Francisco, California
Cerebrovascular Disease, University of Texas Medical School, Houston, Texas


Multifocal transcranial stimulation in chronic ischemic stroke: A phase 1/2a randomized trial
Chiu, D, McCane, CD, Lee, J, John, B, Nguyen, L, Butler, K, Gadhia, R, Misra, V, Volpi, JJ, Verma, A & Helekar, SA 2020, , Journal of Stroke and Cerebrovascular Diseases, vol. 29, no. 6, 104816. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104816

Cerebrovascular Disease in Patients with COVID-19: A Review of the Literature and Case Series
Reddy, ST, Garg, T, Shah, C, Nascimento, FA, Imran, R, Kan, P, Bowry, R, Gonzales, N, Barreto, A, Kumar, A, Volpi, J, Misra, V, Chiu, D, Gadhia, R & Savitz, SI 2020, , Case Reports in Neurology, vol. 12, no. 2, pp. 199-209. https://doi.org/10.1159/000508958

Evaluation of the harmony exoskeleton as an upper extremity rehabilitation tool after stroke
Ogden, EM, Chiu, D, Clearman, RR, Card, C & Deshpande, AD 2018, . in 2017 International Symposium on Wearable Robotics and Rehabilitation, WeRob 2017. Institute of Electrical and Electronics Engineers Inc. pp. 1-2, 2017 International Symposium on Wearable Robotics and Rehabilitation, WeRob 2017, Houston, United States, 11/5/17. https://doi.org/10.1109/WEROB.2017.8383834

Benefits of stroke treatment delivered using a mobile stroke unit trial
Yamal, JM, Rajan, SS, Parker, SA, Jacob, AP, Gonzalez, MO, Gonzales, NR, Bowry, R, Barreto, AD, Wu, TC, Lairson, DR, Persse, D, Tilley, BC, Chiu, D, Suarez, JI, Jones, WJ, Alexandrov, A & Grotta, JC 2018, , International Journal of Stroke, vol. 13, no. 3, pp. 321-327. https://doi.org/10.1177/1747493017711950

The HOPES Registry – Houston Methodist Hospital Outcomes-based Prospective Endpoints in Stroke
Gadhia, RR, McCane, D, Lee, J, Ling, KC, Jiang, K & Chiu, D 2018, Journal of Stroke and Cerebrovascular Diseases. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.06.029

Challenge and yield of enrolling racially and ethnically diverse patient populations in low event rate clinical trials
Sheffet, AJ, Howard, G, Sam, A, Jamil, Z, Weaver, F, Chiu, D, Voeks, JH, Howard, VJ, Hughes, SE, Flaxman, L, Longbottom, ME & Brott, TG 2018, , Stroke, vol. 49, no. 1, pp. 84-89. https://doi.org/10.1161/STROKEAHA.117.018063

Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial
Hess, DC, Wechsler, LR, Clark, WM, Savitz, SI, Ford, GA, Chiu, D, Yavagal, DR, Uchino, K, Liebeskind, DS, Auchus, AP, Sen, S, Sila, CA, Vest, JD & Mays, RW 2017, , The Lancet Neurology, vol. 16, no. 5, pp. 360-368. https://doi.org/10.1016/S1474-4422(17)30046-7

Enrollment volume effect on risk factor control and outcomes in the SAMMPRIS trial
Chiu, D, Klucznik, RP, Turan, TN, Lynn, MJ, McCane, CD, Katz, LB, Nizam, A, Derdeyn, CP, Fiorella, D, Lane, BF, Montgomery, J, Janis, S & Chimowitz, MI 2015, , Neurology, vol. 85, no. 24, pp. 2090-2097. https://doi.org/10.1212/WNL.0000000000002191

Quantifying cerebrovascular reactivity and identifying regions at risk from cerebrovascular steal with arterial spin labeling
Fung, SH, Diaz, O, Klucznik, RP, Zhang, Y, Britz, GW, Volpi, J, Thomas, AP & Chiu, D 2015, Interventional Neuroradiology, vol. 21S1.

Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): The final results of a randomised trial
Derdeyn, CP, Chimowitz, MI, Lynn, MJ, Fiorella, D, Turan, TN, Janis, LS, Montgomery, J, Nizam, A, Lane, BF, Lutsep, HL, Barnwell, SL, Waters, MF, Hoh, BL, Hourihane, JM, Levy, EI, Alexandrov, AV, Harrigan, MR, Chiu, D, Klucznik, RP, Clark, JM, McDougall, CG, Johnson, MD, Pride, GL, Lynch, JR, Zaidat, OO, Rumboldt, Z & Cloft, HJ 2014, , The Lancet, vol. 383, no. 9914, pp. 333-341. https://doi.org/10.1016/S0140-6736(13)62038-3

Transcranial laser therapy in acute stroke treatment: Results of neurothera effectiveness and safety trial 3, a phase III clinical end point device trial
Hacke, W, Schellinger, PD, Albers, GW, Bornstein, NM, Dahlof, BL, Fulton, R, Kasner, SE, Shuaib, A, Richieri, SP, Dilly, SG, Zivin, J, Lees, KR, Zivin, JA, Broderick, J, Ivanova, A, Johnston, K, Norrving, B, Albars, G, Alexandrov, A, Brown, D, Capone, P, Chiu, D, Clark, W, Cochran, J, Deredyn, C, Devlin, T, Hickling, W, Howell, G, Huang, D, Hussain, S, Mallenbaum, S, Moonis, M, Nash, M, Rymer, M, Taylor, R, Tremwel, M, Buck, B, Perez, J, Gerloff, C, Greiwing, B, Grond, M, Hamman, G, Haarmeiter, T, Jander, S, Köhrmann, M, Ritter, M, Schallinger, P, Schneider, D, Sobesky, J, Steiner, T, Steinmetz, H, Veltkamp, R, Weimar, C, Gruber, F, Andersson, B, Welin, L, Leys, D, Tatlisumak, T, Luft, A, Lyrer, P, Michel, P, Molina, C & Segura, T 2014, , Stroke, vol. 45, no. 11, pp. 3187-3193. https://doi.org/10.1161/STROKEAHA.114.005795

Management of vascular risk factors in the carotid revascularization endarterectomy versus stenting trial (CREST)
Meschia, JF, Voeks, JH, Leimgruber, PP, Mantese, VA, Timaran, CH, Chiu, D, Demaerschalk, BM, Howard, VJ, Hughes, SE, Longbottom, M, Howard, AG & Brott, TG 2014, , Journal of the American Heart Association, vol. 3, no. 6, 001180. https://doi.org/10.1161/JAHA.114.001180

Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS)
Fiorella, D, Derdeyn, CP, Lynn, MJ, Barnwell, SL, Hoh, BL, Levy, EI, Harrigan, MR, Klucznik, RP, McDougall, CG, Pride, GL, Zaidat, OO, Lutsep, HL, Waters, MF, Hourihane, JM, Alexandrov, AV, Chiu, D, Clark, JM, Johnson, MD, Torbey, MT, Rumboldt, Z, Cloft, HJ, Turan, TN, Lane, BF, Janis, LS & Chimowitz, MI 2012, , Stroke, vol. 43, no. 10, pp. 2682-2688. https://doi.org/10.1161/STROKEAHA.112.661173

Restenosis after carotid artery stenting and endarterectomy: A secondary analysis of CREST, a randomised controlled trial
Lal, BK, Beach, KW, Roubin, GS, Lutsep, HL, Moore, WS, Malas, MB, Chiu, D, Gonzales, NR, Burke, JL, Rinaldi, M, Elmore, JR, Weaver, FA, Narins, CR, Foster, M, Hodgson, KJ, Shepard, AD, Meschia, JF, Bergelin, RO, Voeks, JH, Howard, G & Brott, TG 2012, , The Lancet Neurology, vol. 11, no. 9, pp. 755-763. https://doi.org/10.1016/S1474-4422(12)70159-X

Stenting versus aggressive medical therapy for intracranial arterial stenosis
Chimowitz, MI, Lynn, MJ, Derdeyn, CP, Turan, TN, Fiorella, D, Lane, BF, Janis, LS, Lutsep, HL, Barnwell, SL, Waters, MF, Hoh, BL, Hourihane, JM, Levy, EI, Alexandrov, AV, Harrigan, MR, Chiu, D, Klucznik, RP, Clark, JM, McDougall, CG, Johnson, MD, Pride, GL, Torbey, MT, Zaidat, OO, Rumboldt, Z & Cloft, HJ 2011, , New England Journal of Medicine, vol. 365, no. 11, pp. 993-1003. https://doi.org/10.1056/NEJMoa1105335

Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Silver, FL, Mackey, A, Clark, WM, Brooks, W, Timaran, CH, Chiu, D, Goldstein, LB, Meschia, JF, Ferguson, RD, Moore, WS, Howard, G & Brott, TG 2011, , Stroke, vol. 42, no. 3, pp. 675-680. https://doi.org/10.1161/STROKEAHA.110.610212

Vascular Disease
Chiu, D 2011, . in Neurology Secrets. Elsevier, pp. 269-282. https://doi.org/10.1016/B978-0-323-05712-7.00017-9


  • English